Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.30%132.640.6%$652.41m
PFEPfizer Inc.
-0.87%32.670.8%$563.97m
MRKMerck & Co., Inc.
-0.58%61.480.6%$492.39m
BMYBristol-Myers Squibb Company
-0.60%56.431.4%$401.07m
ABBVAbbVie, Inc.
0.20%69.992.1%$354.76m
LLYEli Lilly and Company
-0.98%77.041.0%$319.23m
AZNAstraZeneca PLC Sponsored ADR
0.10%29.111.3%$173.16m
GSKGlaxoSmithKline plc Sponsored ADR
-0.72%38.770.2%$116.31m
NVSNovartis AG Sponsored ADR
-0.49%82.780.2%$105.79m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.33%45.190.1%$84.88m
SNYSanofi Sponsored ADR
0.33%48.240.2%$56.48m
LCILannett Company, Inc.
3.31%15.6038.7%$9.62m
SCMPSucampo Pharmaceuticals, Inc. Class A
1.99%10.2514.4%$4.57m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%4.052.2%$0.21m
EPIXESSA Pharma Inc
0.00%0.340.0%$0.06m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has three product candidates in clinical development and several preclinical molecules in lead optimization. The company was founded in 1991 and is headquartered in Sunnyvale, CA.